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With advances in laboratory technology, an increasing number of potentially pathogenic CNVs is rec-
ognised. The phenotypic effects of some CNVs are well characterised, however, it remains unclear how
much information reaches the parents of affected children and by what route. The 22q11.2 deletion
syndrome (del22q11.2) is caused by the deletion of approximately 40 genes from the long arm of
chromosome 22 and was ﬁrst described in 1955 [1]. Our study reports the extent to which parents of an
affected child are aware of the various manifestation of the condition and describes how they ﬁrst
learned about these potential problems.
 2013 The Authors. Published by Elsevier Masson SAS. All rights reserved.Dear Editor,
With advances in laboratory technology, an increasing number
of potentially pathogenic CNVs is recognised. The phenotypic ef-
fects of some CNVs are becoming increasingly well-characterised,
however, it remains unclear how much information reaches the
parents of affected children and by which route.
The 22q11.2 deletion syndrome (22q11.2DS, also known as Velo-
Cardio-Facial Syndrome, Shprintzen syndrome and Di George
syndrome) is caused by the deletion of approximately 40 genes
from the long arm of chromosome 22 and was ﬁrst described in
1955 [1] (see Ref. [2]).
22q11.2DS is associated with physical problems, developmental
delay and psychiatric conditions. The incidence of palatal anomalies
is 69e98% [3,4], while heart and kidney defects are reported to
occur at 74e82% andw37%, respectively [3,4]. Developmental delay
is common, including learning disability 99% [4] and speech delayr the terms of the Creative
tricted use, distribution, and
thor and source are credited.
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Published by Elsevier Masson SAS90% [5]. Psychiatric disorders (reported range 73e80% [6,7]) include
obsessive-compulsive disorder (14e33%) [8,9]; psychosis (30%)
[10], and schizophrenia (21e24%)[8,10], and depressive (6e18%)
[6,7,10,11] and anxiety disorder (44e53%) [6,11].
We aimed to establish the extent to which parents of a child
with 22q11.2DS are aware of the various manifestation of the
condition and describe how they ﬁrst learned about these potential
problems.
We conducted a survey, via the Bristol Online System (BOS),
which was advertised on the website of two UK-based 22q11.2DS
support organisations. A paper form of the survey was also
completed by parents at the annual conference of one of these
organisations in 2010. We opted for recruitment through support
organisations rather than clinical settings, because the latter
strategy would have presented a more narrow range of parental
experiences. Fifty seven parents from the UK & Ireland took part; 7%
of whom reported having 22q11.2DS themselves. Their children’s
reported ages ranged from <1 to 9 years.
Table 1 presents the ﬁndings.
Almost all parents (99%) were aware of developmental delay
(100% for learning difﬁculties and 98% for speech delay). Approxi-
mately half of the parents who indicated awareness had learned
about these issues from clinicians (50% and 55%), either at diagnosis
or later. The internet was themost frequently reported other source
of information about developmental delay (23e33%).. All rights reserved.
Table 1
Parental awareness (UK) and ﬁrst source of information of manifestations of del22q11.2
Parents reporting awareness Physical Developmental Psychiatric
Palate
defects
Heart
defects
Kidney
defects
Learning
difﬁculties
Speech delay Obsessions/
compulsions
Psychosis/
schizophrenia
Depression Anxiety
51/54 (94.4%) 50/54 (92.6%) 45/54 (83.3%) 54/54 (100%) 53/54 (98.2%) 37/54 (68.5%) 46/54 (85.2%) 44/54 (81.5%) 42/54 (77.8%)
Information
from
clinicians
At diagnosis
in clinic
20 (39.2%) 25 (50.0%) 11 (24.4%) 16 (29.6%) 20 (37.7%) 4 (10.8%) 4 (8.7%) 4 (9.1%) 4 (9.5%)
Later by
geneticists/
doctors
10 (19.6%) 7 (14.0%) 17 (37.8%) 11 (20.4%) 9 (17.0%) 5 (13.5%) 10 (21.7%) 8 (18.2%) 6 (14.3%)
Information
from other
sources
Internet 13 (25.5%) 6 (12.0%) 11 (24.4%) 18 (33.3%) 12 (22.6%) 16 (43.2%) 20 (43.5%) 19 (43.2%) 17 (40.5%)
Friend/support
groups
1 (2.0%) 1 (2.0%) 0 (0%) 1 (1.9%) 0 (0%) 5 (13.5%) 6 (13.0%) 6 (13.6%) 6 (14.3%)
Books/leaﬂets 2 (3.9%) 1 (2.0%) 4 (8.9%) 4 (7.4%) 3 (5.7%) 3 (8.11%) 4 (8.7%) 4 (9.1%) 4 (9.5%)
Other 5 (9.8%) 10a (20%) 2a (4.4%) 4 (7.4%) 9 (17.0%) 4 (10.8%) 2 (4.4%) 3 (6.8%) 5 (11.9%)
a Includes when physical health condition was diagnosed before the 22q11.2 deletion.
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associated with 22q11.2DS (palate, heart or kidney defects, range
83e94%); the majority had learned about these from clinicians
(62%, range 59e64%), with the internet representing the most
frequently reported other source of information (except for heart
defects).
With regard to psychiatric manifestations, parental awareness
ranged from 69% (obsessions/compulsions) to 85% (psychosis/
schizophrenia), with an average over the four conditions of 78%.
Here, the most frequently reported source of information was the
internet (41e44%). Clinicians were reported as ﬁrst source of in-
formation by between 24% (obsessions/compulsions and anxiety)
and 30% (psychosis/schizophrenia) of parents (average 27%).
We examinedwhether therewas a difference in themain source
of information (clinicians versus other sources in Table 1) between
physical, developmental manifestations, and psychiatric manifes-
tations (McNemar’s test for matched pair samples, using exact
binomial probability calculations, 2-tailed p; http://www.
vassarstats.net/propcorr.html).
With regard to physical manifestations, clinicians were more
likely to inform parents about palate abnormalities compared with
obsessions and compulsions (p ¼ .01); psychosis/schizophrenia
(p ¼ .01); depression (p ¼ .01); and anxiety (p ¼ .00); as well as
about heart or kidney problems, respectively, rather than obses-
sions/compulsions (both p ¼ .00); psychosis/schizophrenia (both
p ¼ .00); depression (both p ¼ .00) and anxiety (both p ¼ .00).
Parents were also more likely to have learned about develop-
mental delay through clinicians, compared with psychiatric prob-
lems. This was the case for speech delay and obsessions/
compulsions (p ¼ .01); psychosis/schizophrenia (p ¼ .03); depres-
sion and anxiety (p¼ .02, p¼ .01) as well as learning difﬁculties and
obsessions/compulsions and anxiety (both p ¼ .01); however, the
rates for learning difﬁculties and psychosis/schizophrenia (p ¼ .08)
and depression (p ¼ .08) did not differ, indicating that if clinicians
informed parents about learning difﬁculties, they were also likely
to inform them about psychiatric conditions.
Finally, when asked about the main source of information about
manifestations associated with 22q11.2DS, 44% of parents reported
the internet, 28% clinicians, 20% friends and support groups and 7%
books/leaﬂets.
Our ﬁnding of reduced likelihood of divulgence at diagnosis of
risk of psychiatric disorders, compared with other manifestations,
is in agreement with a study of 41 parents of offspring with
22q11.2DS in the US [12], indicating the generalizability of these
ﬁndings across different countries and healthcare systems. In the
Hercher and Bruenner study, 97% of parents were aware of psy-
chiatric disorders, compared with 78% in the current study, adifference likely to be attributable to the fact that the former study
was based on offspring ranging in age from<1 to 38 years, of whom
24%were affected with schizophrenia. The two studies also differ in
the reported rates of divulgence of information at diagnosis, which
are higher for the US study: risk of psychiatric illness (39% [12],
compared with 9e11% in the current study); heart defects (77%
versus 50%) and learning difﬁculties (74% versus 30%), potentially
reﬂecting differences in practice between the US and the UK/
Ireland. A considerable number of parents in our survey did,
however, indicate receiving this information from clinicians (ge-
neticists or other doctors) at a later time.
Our ﬁndings are also in line with a survey by Martin et al. [13] of
54 genetic counsellors, who indicated that during the initial ses-
sion, they were less likely to discuss psychiatric problems associ-
ated with 22q11.2DS, compared with physical health conditions
having a later age of onset. The majority of counsellors in this study
did nevertheless feel it was important to disclose risk of psychiatric
disorder.
We expect that an increasing number of children will be diag-
nosed with medical conditions caused by CNVs. With this letter we
hope to prompt a discussion about the appropriate time and ways
to divulge information about speciﬁc aspects of genetic syndromes
to parents of affected children.
It is difﬁcult to decide when to inform parents of the range of
possible manifestations associated with a pathogenic CNV. Around
birth, or at the time of diagnosis, physical problems such as a heart
defect or cleft lip/palate may represent more pressing matters to
discuss than risk of a psychiatric disorder, such as schizophrenia,
which is more likely to become a concern once the child reaches
adolescence. Providing too much information may be over-
whelming and unduly burden parents at an early stage. On the
other hand, if this information is not made available, parents may
ﬁnd themselves left to their own devices trying to interpret, un-
derstand and cope with changes in their child’s behaviour.
The study by Martin et al. [13] conducted interviews with the
parents of four adult offspring with 22q11.2DS and schizophrenia.
Three indicated they would have preferred to have been informed
about psychiatric risks at the time of diagnosis of 22q11.2DS, even if
other urgent physical health problems were present. Even though
based on retrospective accounts provided by a very small sample of
parents whose offspring developed a serious mental health disor-
der, this study does suggest that psychiatric risks should ﬁrst be
addressed during the early stages of genetic diagnosis. The high
rates of childhood psychiatric problems reported for 22q11.2DS as
well as the evidence that early diagnosis and treatment can have
both short- as well as long-term beneﬁcial impacts [14, 15] provide
further support for this approach.
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chiatric problemsareﬁrst reviewedwith theparents during the initial
genetic counselling session(s), while later-onset psychopathology is
discussed during follow-up sessions. Parents need to be aware that
they should contact their family physician (General Practitioner) if
they are concerned about their child’s behaviour, with the possibility
of referral to specialist psychiatric services. By the time the patient
reaches later adolescence they should be offered their own counsel-
ling session, as part of which the routes they can follow if they expe-
rience psychiatric problems are explained.
Longitudinal studies of patients with 22q11.2DS are still rare
and based on small samples, however, possible predictors of risk
of psychosis are beginning to emerge (see Refs. [16,17]), and this
may in the future lead to patient-tailored approaches to coun-
selling (although more so for older children than very young
patients).
Martin et al. found that almost half (48%) of genetic counsellors
were uncomfortable with discussing psychiatric disorder [13].
Perceived barriers included lack of knowledge about these condi-
tions and their treatment, as well as the stigma associated with
mental disorder. Findings by Hercher and Bruenner indicated that
stigma is also a concern for parents, with 42% reporting they had
kept information about psychiatric problems associated with
22q11.2DS from other people for fear of stigmatisation, even
though the majority of parents in this study (72%) also indicated
this had rarely or never happened [12]. These ﬁndings suggest a
need for training for genetic counsellors about mental health
conditions and their treatment as well as the best ways to divulge
this information, whilst aiming to reduce parental anxiety about
societal bias with regards to these conditions. Furthermore, the
follow-up sessions we propose would help parents consolidate and
add to their understanding of mental health issues associated with
their child’s genetic syndrome.
Our study found that the internet was the most frequently re-
ported source of information about psychiatric disorder (41e44% of
parents), which is lower than the ﬁgure of 62% reported by Hercher
and Bruenner [12]; however, no direct comparison is possible
because we asked about parents’ ﬁrst source of information, while
Hercher and Bruenner asked about all sources and allowed parents
to endorse all options that applied.
Many CNV conditions, such as 22q11.2DS are rare; one parent
wrote “Most of the information I got came from . the internet,
simply due tomostmedical professionals having never come across
this disorder before”. The internet can be an important ﬁrst port of
call, or additional source of information, provided the website is
based on appropriately evaluated clinical and scientiﬁc informa-
tion. One parent left the following comment as part of our survey:“Too little, too late. In this modern age of technology, please give
parents approved websites in order to get valid information”.
However, it is also important to recognise that an internet
resource cannot replace the interaction with a clinical professional.
Another parent commented: “We were pointed at the internet and
left to ﬁnd out for ourselves”.
In addition to the development of high-quality websites to
which parents can initially turn, mechanisms need to be in place to
ensure that concerned parents know how to seek clinical advice
and talk to well-informed clinicians.References
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